Open AccessFDA Approval for Trelstar 22.5 mg, 6-Month IM GnRH Agonist for Palliative Treatment of Advanced Prostate Cancer
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000371024.24799.f4
Subject(s) - prostate cancer , medicine , agonist , drug approval , gynecology , cancer , oncology , pharmacology , drug , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom